Related Experiment Video
Updated: Feb 17, 2026

Mitigation of Blood Borne Cell Attachment to Metal Implants through CD47-Derived Peptide Immobilization
Published on: December 3, 2020
Matrix metalloproteinase-9 might affect adaptive immunity in non-ST segment elevation acute coronary syndromes by
Giulia Angelini1, Davide Flego1, Ramona Vinci1
1Department of Cardiovascular and Thoracic Sciences, Catholic University of the Sacred Heart, Fondazione Policlinico Universitario A. Gemelli, Largo A. Gemelli, 8-00168 Rome, Italy.
Insights
Matrix metalloproteinase-9 (MMP-9) enhances CD31 cleavage in CD4+ T-cells of acute coronary syndrome (ACS) patients. Inhibiting MMP-9 may offer a therapeutic target for T-cell dysregulation in ACS.
Area of Science:
- Immunology
- Cardiovascular Medicine
- Molecular Biology
Background:
- Adaptive immunity dysregulation, indicated by effector T-cell activity, may contribute to coronary instability in acute coronary syndrome (ACS).
- Cleavage and shedding of the functional CD31 domain 1-5 are linked to uncontrolled lymphocyte activation.
- Matrix metalloproteinase-9 (MMP-9) is implicated in CD31 cleavage and elevated in ACS patients.
Purpose of the Study:
- To investigate the mechanisms of CD31 dysregulation in ACS.
- To determine the role of MMP-9 in CD31 cleavage on T-cells in ACS patients.
Main Methods:
- Flow cytometry was used to analyze CD31 cleavage on CD4+ T-cells from ACS patients, stable angina (SA) patients, and controls (CTRL).
- Two CD31 antibodies were employed to differentiate between functional (domain 1-5) and non-functional (domain 6) epitopes.
- ELISA was used to measure MMP-9 production in T-cell supernatants.
Main Results:
- The ratio of CD31 functional domain 1-5 to domain 6 was significantly lower in ACS patients compared to SA and CTRL groups.
- This ratio remained lower in ACS patients even after T-cell stimulation.
- Elevated MMP-9 production was observed in stimulated CD4+ T-cells from ACS patients, and MMP-9 inhibition reduced CD31 domain 1-5 expression.
Conclusions:
- Enhanced MMP-9 release is a key factor in the cleavage and shedding of the functional CD31 domain 1-5 on CD4+ T-cells in ACS patients.
- This MMP-9-mediated CD31 cleavage represents a potential therapeutic target for modulating T-cell dysregulation in ACS.
Aims:
In patients with acute coronary syndrome (ACS), the higher activity of effector T-cells suggests that mechanisms involving adaptive immunity dysregulation might play a role in coronary instability. The shedding of the functional CD31 domain 1-5 leads to uncontrolled lymphocyte activation. In experimental models, matrix metalloproteinase-9 (MMP-9) has been implicated in endothelial CD31 cleavage. Interestingly, higher serum levels of MMP-9 have been observed in ACS. We aim to investigate the mechanisms underlying CD31 dysregulation in ACS.
Methods And Results:
To assess CD31 cleavage on CD4+ T-cells, we analysed by flow cytometry CD4+ T-cells of 30 ACS, 25 stable angina (SA) patients, and 28 controls (CTRL) using two different CD31 antibodies that specifically recognize domain 1-5 or the non-functional membrane-proximal domain 6. The ratio between the domains was significantly lower in ACS than in SA and CTRL (P = 0.002 ACS vs. SA; P = 0.002 ACS vs. CTRL). After stimulation with anti-CD3/CD28, the 1-5/6 domain ratio was significantly lower in ACS than in SA (P = 0.005). ELISA of supernatants obtained from T-cell receptor-stimulated CD4+ T-cells showed higher production of MMP-9 in ACS than in SA (P < 0.001). CD31 domain 1-5 expression in activated CD4+ T-cells from ACS patients increased after treatment with a specific MMP-9 inhibitor (P = 0.042).
Conclusion:
Our study suggest that enhanced MMP-9 release plays a key role in determining the cleavage and shedding of the functional CD31 domain 1-5 in CD4+ T-cells of ACS patients. This mechanism might represent an important therapeutic target to modulate T-cell dysregulation in ACS.
Related Concept Videos
Myocarditis I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Role of Matrix Metalloproteases in Degradation of ECM
Intracellular Signaling Affects Focal Adhesions
Some...
Acute Coronary Syndrome I: Introduction

